ME
Medacta Group S.A.
MEDGF · OTC
$137.50 +0.00% (+$0.00)
1M -8.37%
Bulios Fair Price
$71.74
47.8% downside
Current Price
$137.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MEDGF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
-
N/A P/B N/A
P/FFO N/A
P/E N/A
Growth
91 /100
Growing Book val. growth 30.62%
FCF growth 107.36%
EPS growth 57.61%
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
61 /100
Moderate Profitable years 6
EPS volatility 117.61%
Beta 0.98x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MEDGF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Francesco Siccardi
Employees
2,165
Headquarters
Castel San Pietro
Upcoming events
12 MAR
Earnings
Upcoming earnings report